Clinical Trials Browser

Phase 1 × Liver Neoplasms × brivanib × Clear all

NCT00437424 2011-05-04

A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms